Latest News

To support our growth and our preclinical research activities, we're investing in new facilities! We are glad to unveil the new plans for ETAP-Lab's future building in Nancy-Chavigny, in the Brabois forestière business park! 🔬To support our research activity in the fields of dermatology and neurology, our new premises will incorporate larger laboratories, more office space for the support departments and all the facilities to ensure the well-being of our employees, all in a building with a footprint of 1600m², including 700m²

The ETAP-Lab group, specialized in the preclinical evaluation of the efficacy of innovative therapies for the pharmaceutical industry, is recruiting several people specialized in preclinical in vivo cardiology for its Marseille site SYNCROSOME! Do you want to join a fast-growing, flexible and human-sized organization that designs and carries out customized experimental protocols? Beyond science, we pay particular attention to ethics, animal welfare, sustainable development and the validation of the most recent techniques.   The offers in a few words

Syncrosome is proud to attend the next Heart Failure Drug Discovery & Development Summit as an event partner, which will take place from 31 July to 1 August 2024, in Boston (USA, MA)! We look forward to participating in the 3rd HF Drug Discovery & Development Summit, which returns to tackle the major challenges facing preclinical heart failure drug development by bringing together more than 50 biopharmas delve into targeting, stratifying and treating cardiomyopathies with greater precision. A fine programme of scientific

📺 ETAP-Lab talks to IBTV at BIO 2024 about our current projects and activity, and to present our innovations. Jérôme Bernard, CBO, explains: "As a CRO, we have to be at the forefront of innovation to help our clients to derisk their molecules and programs". ▶️ Discover the integral interview on IBTV channel.

ETAP-Lab will attend the upcoming FENS Forum 2024 on next June 26-29, 2024, in Vienna (Austria).   FENS Forum 2024, taking place in Vienna this year, is organized by the Federation of European Neuroscience Societies (FENS), the Austrian Neuroscience Association (ANA) and the Hungarian Neuroscience Society. The FENS Forum is Europe’s largest neuroscience congress, covering all areas of neuroscience from basic to translational research. It will feature an exciting programme of plenary and special lectures, scientific symposia, technical workshops, special interest events,

ETAP-Lab sera présent aux Journées Aliments & Santé à La Rochelle (France) le 19 et 20 juin 2024 - créées à l’initiative du CRITT Agro-Alimentaire de La Rochelle - manifestation de référence pour les professionnels de l’agro-alimentaire et la plus importante convention d’affaires européenne du secteur.   🍏 Découvrez nos solutions dédiées à l'industrie agroalimentaire Nous souhaitons rencontrer des laboratoires pour les accompagner dans l'évaluation de leurs ingrédients naturels, fonctionnels et nouveaux aliments, et soutenir leur R&D pour répondre aux enjeux de l'alimentation

Discover on 13 June in Strasbourg the Nextmed Day: bringing the future of healthcare closer together! ➡ETAP-Lab, represented by its CEO Nicolas Violle, will be taking part in the round table "France 2030: how to support excellence in the healthcare sector in the territories?" This round table will be featuring Charles-Edouard Escurat from the Agence de l'Innovation en santé, Jean-Luc Dimarcq from the IHU Strasbourg, and moderated by Jean Sibilia. 👉 You can find the full programme with other round tables and pitches

🔬 We wanted to share with you one of our cell image that shows primary cortical rat neurons (DIV14) stained for PSD-95 (synapses) in green, MAP2 (dendrites) in red and DAPI (nuclei) in blue. Each little green dot shows an active synapse happening between two neurons! 🧠Ahmad Allouche, one of our in vitro expert, explains: "About the synaptic degeneration mechanism, it occurs early in neurodegenerative diseases and correlates with cognitive decline. Increased levels of synaptic proteins have been detected in the CSF

ETAP-Lab, including its brands SYNCROSOME and STROK@LLIANCE, will attend the upcoming 2024 BIO International Convention on next June 3 - 6, 2024, in San Diego, California for partnering opportunities. This annual BIO International Convention, hosted by Biotechnology Innovation Organization (BIO), is the world’s largest industry gathering, bringing together thousands of global biotechnology and biopharmaceutical leaders.   🎯 Our broad offering, tailored to your challenges You look forward accelerating the development of your drugs and/or medical devices in Dermatology, Neurology, Gastroenterology or Cardiology thanks to preclinical studies

🌍Today is World Parkinson’s Day, dedicated to increase public awareness and understanding of this disease which affects over 10 million people worldwide, making it the second leading of neurodegenerative disease after Alzheimer's. It is also the second most common cause of motor disability after stroke. It is considered that almost 1 in 50 people will be directly affected by this disease during their lifetime. Although widespread, there is currently no cure for the disease. In the Parkinson's disease field, the notion